Oxurion Company

At Oxurion we are dedicated to developing innovative treatments to preserve vision for patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.
Industry: Small&Large Molecules
Headquarters: Heverlee, Vlaams-Brabant, Belgium
Founded Date: 1991

Visit Website
info@oxurion.com
Register and Claim Ownership